Current advances in cancer energy metabolism under dietary restriction: a mini review
Liuxin Yang,
No information about this author
Yudian Shao,
No information about this author
Tingting Gao
No information about this author
et al.
Medical Oncology,
Journal Year:
2024,
Volume and Issue:
41(9)
Published: July 26, 2024
Language: Английский
Cancer metabolic reprogramming and precision medicine-current perspective
Tingting Gao,
No information about this author
Liuxin Yang,
No information about this author
Yali Zhang
No information about this author
et al.
Frontiers in Pharmacology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 17, 2024
Despite
the
advanced
technologies
and
global
attention
on
cancer
treatment
strategies,
continues
to
claim
lives
adversely
affects
socio-economic
development.
Although
combination
therapies
were
anticipated
eradicate
this
disease,
resilient
restorative
nature
of
cancers
allows
them
proliferate
at
expense
host
immune
cells
energetically.
This
proliferation
is
driven
by
metabolic
profiles
specific
type
patient.
An
emerging
field
exploring
reprogramming
(MR)
predict
effective
treatments.
mini-review
discusses
recent
advancements
in
MR
that
have
contributed
predictive,
preventive,
precision
medicine.
Current
perspectives
mechanisms
various
types
prospects
for
personalized
medicine
are
essential
optimizing
outputs
necessary
Language: Английский
Metabolite, immunocyte phenotype, and lymphoma: a Mendelian randomization study
Chenyang Fan,
No information about this author
Pengying Yuan,
No information about this author
Xiangdong Yang
No information about this author
et al.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: Sept. 25, 2024
Recent
studies
have
confirmed
that
metabolites
and
immunocyte
phenotype
may
be
associated
with
the
risk
of
lymphoma.
However,
bidirectional
causality
between
metabolites,
phenotype,
disease
risk,
whether
immunity
is
an
intermediate
mediator
metabolism
lymphoma
still
unclear.
Language: Английский